USPH FY2025 EPS Estimate Lifted by Barrington Research

U.S. Physical Therapy, Inc. (NYSE:USPH) – Analysts at Barrington Research increased their FY2025 earnings estimates for U.S. Physical Therapy in a report issued on Friday, November 7th. Barrington Research analyst M. Petusky now expects that the company will post earnings of $2.56 per share for the year, up from their previous forecast of $2.53. Barrington Research has a “Outperform” rating and a $103.00 price target on the stock. The consensus estimate for U.S. Physical Therapy’s current full-year earnings is $2.67 per share. Barrington Research also issued estimates for U.S. Physical Therapy’s Q4 2025 earnings at $0.61 EPS, Q3 2026 earnings at $0.70 EPS, FY2026 earnings at $2.77 EPS and FY2027 earnings at $3.06 EPS.

U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings data on Tuesday, August 22nd. The company reported $0.90 earnings per share for the quarter. The firm had revenue of $140.66 million during the quarter. U.S. Physical Therapy had a return on equity of 8.78% and a net margin of 5.05%.

A number of other equities analysts have also recently issued reports on the company. Zacks Research upgraded U.S. Physical Therapy to a “hold” rating in a report on Friday, August 8th. JPMorgan Chase & Co. assumed coverage on shares of U.S. Physical Therapy in a research report on Thursday, September 18th. They set an “overweight” rating and a $110.00 target price on the stock. Weiss Ratings reissued a “hold (c)” rating on shares of U.S. Physical Therapy in a research note on Wednesday, October 8th. Finally, Wall Street Zen downgraded shares of U.S. Physical Therapy from a “buy” rating to a “hold” rating in a research note on Sunday, September 21st. One equities research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $110.25.

U.S. Physical Therapy Trading Down 0.7%

NYSE USPH opened at $73.37 on Monday. The stock has a market capitalization of $1.12 billion, a P/E ratio of 32.04, a P/E/G ratio of 4.41 and a beta of 1.47. The business has a 50 day simple moving average of $85.24 and a 200 day simple moving average of $80.18. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.18 and a quick ratio of 1.18. U.S. Physical Therapy has a one year low of $62.77 and a one year high of $101.19.

U.S. Physical Therapy Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 12th. Shareholders of record on Monday, November 17th will be issued a dividend of $0.45 per share. The ex-dividend date is Monday, November 17th. This represents a $1.80 annualized dividend and a yield of 2.5%. U.S. Physical Therapy’s dividend payout ratio is presently 75.63%.

Insider Transactions at U.S. Physical Therapy

In other U.S. Physical Therapy news, CEO Christopher J. Reading sold 2,000 shares of the firm’s stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $83.53, for a total value of $167,060.00. Following the transaction, the chief executive officer directly owned 114,088 shares of the company’s stock, valued at approximately $9,529,770.64. This trade represents a 1.72% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Nancy Ham sold 600 shares of the business’s stock in a transaction dated Thursday, September 11th. The stock was sold at an average price of $81.71, for a total transaction of $49,026.00. Following the sale, the director directly owned 1,994 shares of the company’s stock, valued at approximately $162,929.74. The trade was a 23.13% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders sold 5,061 shares of company stock valued at $426,273. Corporate insiders own 2.00% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the stock. CWM LLC grew its holdings in U.S. Physical Therapy by 17.0% during the third quarter. CWM LLC now owns 968 shares of the company’s stock worth $82,000 after buying an additional 141 shares in the last quarter. PNC Financial Services Group Inc. boosted its holdings in U.S. Physical Therapy by 4.8% during the 3rd quarter. PNC Financial Services Group Inc. now owns 3,091 shares of the company’s stock worth $263,000 after acquiring an additional 142 shares during the last quarter. Assetmark Inc. boosted its holdings in U.S. Physical Therapy by 35.7% during the 2nd quarter. Assetmark Inc. now owns 570 shares of the company’s stock worth $45,000 after acquiring an additional 150 shares during the last quarter. Amalgamated Bank grew its stake in shares of U.S. Physical Therapy by 3.8% in the 3rd quarter. Amalgamated Bank now owns 4,461 shares of the company’s stock worth $379,000 after acquiring an additional 162 shares in the last quarter. Finally, Osaic Holdings Inc. raised its holdings in shares of U.S. Physical Therapy by 1.6% in the second quarter. Osaic Holdings Inc. now owns 10,447 shares of the company’s stock valued at $817,000 after purchasing an additional 166 shares during the last quarter.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.